Meaningful suffix may be in for U.S. biologics, biosimilars
FDA Pushes Back Comment Period for Biosimilar Labeling
Just released: new deadline August?2 for information collection request it submitted to the White House Office of Management and Budget (OMB)
Additional Reading
FDA approves Inflectra, a biosimilar to Remicade
A Rocky Start for Biosimilar Inflectra?
Sandoz launches ZarxioTM (filgrastim-sndz), the first biosimilar in the United States
FDA Information on Biosimilars
Biosimilar switching not suitable for all patients
